Mannkind (MNKD) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.31% |
| Dec 31, 2025 | -140.68% |
| Sep 30, 2025 | 256.60% |
| Jun 30, 2025 | -76.23% |
| Mar 31, 2025 | -15.86% |
| Dec 31, 2024 | 107.64% |
| Sep 30, 2024 | -23.18% |
| Jun 30, 2024 | -0.67% |
| Mar 31, 2024 | 112.80% |
| Dec 31, 2023 | 54.17% |
| Sep 30, 2023 | 196.17% |
| Jun 30, 2023 | 128.69% |
| Mar 31, 2023 | 53.10% |
| Dec 31, 2022 | -33.09% |
| Sep 30, 2022 | 53.02% |
| Jun 30, 2022 | 3.77% |
| Mar 31, 2022 | 11.32% |
| Dec 31, 2021 | -263.70% |
| Sep 30, 2021 | 35.85% |
| Jun 30, 2021 | -65.93% |
| Mar 31, 2021 | 73.93% |
| Dec 31, 2020 | -160.10% |
| Sep 30, 2020 | -15.35% |
| Jun 30, 2020 | -11.15% |
| Mar 31, 2020 | 37.27% |
| Dec 31, 2019 | -29.31% |
| Sep 30, 2019 | 19.84% |
| Jun 30, 2019 | 18.96% |
| Mar 31, 2019 | -74.83% |
| Dec 31, 2018 | 64.12% |
| Sep 30, 2018 | -4.90% |
| Jun 30, 2018 | 23.34% |
| Mar 31, 2018 | 7.10% |
| Dec 31, 2017 | -2.34% |
| Sep 30, 2017 | 10.74% |
| Jun 30, 2017 | -61.06% |
| Mar 31, 2017 | -65.66% |
| Dec 31, 2016 | -110.01% |
| Sep 30, 2016 | 718.22% |
| Jun 30, 2016 | 4.44% |
| Mar 31, 2016 | 92.67% |
| Dec 31, 2015 | -949.35% |
| Sep 30, 2015 | -8.12% |
| Jun 30, 2015 | -10.64% |
| Mar 31, 2015 | 27.79% |
| Dec 31, 2014 | 21.33% |
| Sep 30, 2014 | 45.21% |
| Jun 30, 2014 | -68.67% |
| Mar 31, 2014 | 11.17% |
| Dec 31, 2013 | -4.14% |
| Sep 30, 2013 | -7.64% |
| Jun 30, 2013 | -14.13% |
| Mar 31, 2013 | -8.81% |
| Dec 31, 2012 | 5.64% |
| Sep 30, 2012 | 19.45% |
| Jun 30, 2012 | -29.83% |
| Mar 31, 2012 | -10.97% |
| Dec 31, 2011 | 6.69% |
| Sep 30, 2011 | 16.37% |
| Jun 30, 2011 | -3.12% |
| Mar 31, 2011 | -18.41% |
| Dec 31, 2010 | 24.56% |
| Sep 30, 2010 | -14.16% |